TRAVERE THERAPEUTICS INC

CUSIP: 89422GAA5 Class: Convertible Debt

AGF MANAGEMENT LTD's Holding History (CIK: 0001003518)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 1,050,000 Value ($000) $1,493 Avg Close — Range —
Q3 2025
Shares 8,800,000 Value ($000) $9,921 Avg Close — Range —
Q2 2025
Shares 13,925,000 Value ($000) $13,229 Avg Close — Range —
Q1 2025
Shares 1,275,000 Value ($000) $1,267 Avg Close — Range —
Q4 2024
Shares 2,900,000 Value ($000) $2,762 Avg Close — Range —
Q3 2024
Shares 4,500,000 Value ($000) $3,866 Avg Close — Range —
Q2 2024
Shares 3,750,000 Value ($000) $2,423 Avg Close — Range —